BACKGROUND: An increase in the use of drugs and polypharmacy have been displayed over time in spite of the fact that polypharmacy represents a well known risk factor as regards patients' health due to the adverse drug reactions, drug-drug interactions, and low adherence to drug therapy arising from polypharmacy. For policymakers, as well as for…
BMC Clinical Pharmacology Template
Write in a clean editor, then format for BMC Clinical Pharmacology in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the BMC Clinical Pharmacology format
BMC Clinical Pharmacology is a peer-reviewed journal published by BMC (BioMed Central), covering Pharmacovigilance and Adverse Drug Reactions, Pharmaceutical Practices and Patient Outcomes, Medication Adherence and Compliance.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. BMC Clinical Pharmacology. 2023;12(3):45–58.
Formats any DOI in BMC Clinical Pharmacology style. No sign-up. |
| Publishes research in | Pharmacovigilance and Adverse Drug Reactions Pharmaceutical Practices and Patient Outcomes Medication Adherence and Compliance Opioid Use Disorder Treatment Antibiotics Pharmacokinetics and Efficacy |
| ISSN | 1472-6904 |
| h-index | 51 |
| i10-index | 122 |
| Total citations | 7,221 |
| Top institutions publishing here | University of Minnesota |
| Journal website | www.pubmedcentral.nih.gov |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in BMC Clinical Pharmacology per year
Citation impact of BMC Clinical Pharmacology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in BMC Clinical Pharmacology
BACKGROUND: Spontaneous adverse drug reaction (ADR) reporting is the cornerstone of pharmacovigilance. ADR reporting with Yellow Cards has tremendously improved pharmacovigilance of drugs in many developed countries and its use is advocated by the World Health Organization (WHO). This study was aimed at investigating the knowledge and attitude of doctors in a teaching hospital in…
BACKGROUND: Adverse drug reactions (ADRs) are a frequent cause of mortality and morbidity to patients worldwide, with great associated costs to the healthcare providers including the NHS in England. We examined trends in hospital admissions associated with adverse drug reaction in English hospitals and the accuracy of national reporting. METHODS: Data from the Hospital Episode…
BACKGROUND: The word selectivity describes a drug's ability to affect a particular cell population in preference to others. As part of the current state of art in the search for new therapeutic agents, the property of selectivity is a mode of action thought to have a high degree of desirability. Consequently there is a growing…